FILOSTO, Massimiliano
 Distribuzione geografica
Continente #
NA - Nord America 8.883
AS - Asia 5.124
EU - Europa 2.541
SA - Sud America 1.442
AF - Africa 111
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 18.113
Nazione #
US - Stati Uniti d'America 8.713
SG - Singapore 2.175
BR - Brasile 1.242
CN - Cina 931
HK - Hong Kong 912
VN - Vietnam 385
UA - Ucraina 353
IT - Italia 348
DE - Germania 299
PL - Polonia 287
GB - Regno Unito 273
RU - Federazione Russa 260
TR - Turchia 256
IE - Irlanda 212
FI - Finlandia 206
IN - India 116
BD - Bangladesh 81
AR - Argentina 78
CA - Canada 78
SE - Svezia 63
MX - Messico 58
FR - Francia 52
ZA - Sudafrica 50
AT - Austria 49
IQ - Iraq 45
NL - Olanda 43
JP - Giappone 39
ID - Indonesia 30
EC - Ecuador 28
PY - Paraguay 27
CZ - Repubblica Ceca 24
ES - Italia 23
UZ - Uzbekistan 22
PK - Pakistan 21
VE - Venezuela 17
SA - Arabia Saudita 16
CL - Cile 15
CO - Colombia 14
EG - Egitto 14
IL - Israele 13
LT - Lituania 12
AE - Emirati Arabi Uniti 11
MA - Marocco 11
UY - Uruguay 11
KE - Kenya 9
NP - Nepal 9
PE - Perù 9
CH - Svizzera 8
TN - Tunisia 8
TW - Taiwan 8
CR - Costa Rica 7
JO - Giordania 7
AZ - Azerbaigian 6
BE - Belgio 6
LB - Libano 6
AU - Australia 5
BH - Bahrain 5
DO - Repubblica Dominicana 5
KZ - Kazakistan 5
PA - Panama 5
SN - Senegal 5
AL - Albania 4
ET - Etiopia 4
IR - Iran 4
MU - Mauritius 4
OM - Oman 4
BG - Bulgaria 3
EU - Europa 3
GR - Grecia 3
GT - Guatemala 3
HN - Honduras 3
JM - Giamaica 3
LV - Lettonia 3
PS - Palestinian Territory 3
PT - Portogallo 3
BB - Barbados 2
BY - Bielorussia 2
CG - Congo 2
GE - Georgia 2
KH - Cambogia 2
KR - Corea 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DZ - Algeria 1
GD - Grenada 1
HU - Ungheria 1
IS - Islanda 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
MG - Madagascar 1
MN - Mongolia 1
MS - Montserrat 1
MY - Malesia 1
Totale 18.108
Città #
Fairfield 1.311
Singapore 930
Hong Kong 911
Ashburn 865
Woodbridge 684
Seattle 601
Houston 541
Wilmington 452
Cambridge 430
Princeton 402
Warsaw 284
Jacksonville 273
New York 269
Istanbul 222
Ann Arbor 214
Dublin 211
Los Angeles 206
Beijing 202
The Dalles 196
Chandler 150
Des Moines 127
Ho Chi Minh City 127
Helsinki 122
Moscow 113
Dallas 107
Buffalo 104
Redondo Beach 104
San Diego 91
São Paulo 89
Munich 82
Hanoi 78
London 74
Brescia 73
Chicago 51
Shanghai 50
Nanjing 49
Boardman 43
Nuremberg 42
Rio de Janeiro 42
Turku 40
San Francisco 37
Tokyo 35
Santa Clara 32
Brooklyn 30
Johannesburg 29
Lappeenranta 28
Belo Horizonte 26
Porto Alegre 26
Vienna 25
Atlanta 24
Milan 24
Guangzhou 23
Montreal 23
Romola 23
Dearborn 22
Poplar 22
Pune 22
Toronto 22
Tashkent 21
Curitiba 20
Stockholm 19
Brasília 18
Chennai 18
Orem 18
Tianjin 18
Changsha 17
Denver 17
Norwalk 17
Phoenix 17
Dhaka 16
Manchester 16
Baghdad 15
Da Nang 15
Goiânia 15
Jinan 15
Nanchang 15
Shenyang 15
Boston 14
Guayaquil 14
Mexico City 14
Salt Lake City 14
Amsterdam 13
Guarulhos 13
Dong Ket 12
Haiphong 12
Lancaster 12
Thái Nguyên 12
Brno 11
Frankfurt am Main 11
Kilburn 11
Naples 11
New Delhi 11
Olomouc 11
Sorocaba 11
Ankara 10
Asunción 10
Biên Hòa 10
Charlotte 10
Islington 10
Jiaxing 10
Totale 12.024
Nome #
Very late-onset friedreich ataxia with laryngeal dystonia 305
A Novel Mutation in the Stalk Domain of KIF5A Causes a Slowly Progressive Atypical Motor Syndrome 244
A complex craniovertebral junction malformation in a patient with late onset glycogenosis 2 234
COVID-19 impact on consecutive neurological patients admitted to the emergency department 215
Cortico-spinal tDCS in ALS: A randomized, double-blind, sham-controlled trial 192
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 188
A high-dose bortezomib neuropathy with sensory ataxia and myelin involvement. 178
A new mutation in the mitochondrial tRNAAla gene in a patient with ophthalmoplegia and dysphagia 165
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 163
Choreo-athetosis in LRRK2 R1441C mutation: expanding the clinical phenotype. 156
A PCR-based protocol to accurately size C9orf72 intermediate-length alleles. 154
A novel mitochondrial tRNA(Ala) gene variant causes chronic progressive external ophthalmoplegia in a patient with Huntington disease. 153
Small nerve fiber pathology in critical illness 152
Interpretation of the epigenetic signature of facioscapulohumeral muscular dystrophy in light of genotype-phenotype studies 151
Critical illness myopathy 145
Idiopathic hypocomplementemic urticarial vasculitis-linked neuropathy 138
Coffee and amyotrophic lateral sclerosis: A possible preventive role 134
A novel CAPN1 mutation causes a pure hereditary spastic paraplegia in an Italian family 132
Snake-Eye Myelopathy and Surgical Prognosis: Case Series and Systematic Literature Review 127
Hemangioma of the semimembranosus muscle in a patient with late-onset glycogenosis II 125
Gold Coast Criteria in ALS Diagnosis: A Real-World Experience 125
Novel mitochondrial tRNALeu(CUN) transition and D4Z4 partial deletion in a patient with a facioscapulohumeral phenotype 124
Neuropathology of mitochondrial diseases. 121
Autosomal recessive Bethlem myopathy: A clinical, genetic and functional study 121
Mitochondrial DNA-related disorders. 119
The brain in late-onset glycogenosis II: a structural and functional MRI study. 118
MR Neurography in Diagnosing Nondiabetic Lumbosacral Radiculoplexus Neuropathy 116
Exploring Olfactory Function and Its Relation with Behavioral and Cognitive Impairment in Amyotrophic Lateral Sclerosis Patients: A Cross-Sectional Study. 116
Poor Outcome in a Mitochondrial Neurogastrointestinal Encephalomyopathy Patient with a NovelTYMPMutation: The Need for Early Diagnosis 112
Muscle pain in mitochondrial diseases: a picture from the Italian network 112
C9orf72 Intermediate Repeats Confer Genetic Risk for Severe COVID-19 Pneumonia Independently of Age 112
Analysis of C9Orf72 Expansions in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Preliminary Data 111
Editorial: Iron and Neurodegeneration 108
Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD) 107
Guillain-Barré syndrome and COVID-19: A 1-year observational multicenter study 104
Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3 103
Magnetic resonance imaging of the peripheral nerve 102
Assessing the Role of Anti rh-GAA in Modulating Response to ERT in a Late-Onset Pompe Disease Cohort from the Italian GSDII Study Group 100
Protein misfolding, amyotrophic lateral sclerosis and guanabenz: Protocol for a phase II RCT with futility design (ProMISe trial) 99
Impact of environmental factors and physical activity on disability and quality of life in CIDP 97
Advances in quantitative imaging of genetic and acquired myopathies: Clinical applications and perspectives 95
Autosomal dominant psychiatric disorders and mitochondrial DNA multiple deletions: Report of a family 94
Human leukocyte antigens class II in CIDP spectrum neuropathies 92
Psychosocial impact of sport activity in neuromuscular disorders 92
Late and severe myopathy in a patient with glycogenosis VII worsened by cyclosporin and amiodarone 91
Eyelid ptosis from sympathetic nerve dysfunction mistaken as myopathy: A simple test to identify this condition 85
Prevalence of asymptomatic vertebral fractures in late-onset pompe disease 85
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population 85
A 5-year clinical follow-up study from the Italian National Registry for FSHD 84
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 84
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis 84
Genetic correlation between amyotrophic lateral sclerosis and schizophrenia 84
A mobile app for patients with Pompe disease and its possible clinical applications 84
Muscle biopsy displaying "double trouble" pathology: Combined features of periodic paralysis and dermatomyositis 84
Antioxidant agents have a different expression pattern in muscle fibers of patients with mitochondrial diseases 82
Alterazioni delle fibre sensitive di piccolo calibro intra-epidermiche in pazienti con critical illness myopathy and neuropathy. Dati preliminari. 81
Vaccination recommendations for patients with neuromuscular disease 81
Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy 79
Mitochondrial diseases: Advances and issues 79
Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase 78
Strategies for treating mitochondrial disorders: An update 78
A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes 78
Prognostic Usefulness of Motor Unit Number Index (MUNIX) in Patients Newly Diagnosed with Amyotrophic Lateral Sclerosis 77
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis 77
The genetic basis of undiagnosed muscular dystrophies and myopathies 77
Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (Nature Genetics, (2021), 53, 12, (1636-1648), 10.1038/s41588-021-00973-1) 77
Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy 76
Lipomatosis incidence and characteristics in an Italian cohort of mitochondrial patients 76
ASAH1 variant causing a mild SMA phenotype with no myoclonic epilepsy: A clinical, biochemical and molecular study 76
A non-syndromic hearing loss caused by very low levels of the mtDNA A3243G mutation 76
A Comprehensive Update on Late-Onset Pompe Disease 74
Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions 74
Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis? 74
Chronic ophthalmoparesis in limb girdle muscular dystrophy 1c 74
Juvenile-Onset Recurrent Rhabdomyolysis Due to Compound Heterozygote Variants in the ACADVL Gene 73
RELEVANCE OF DIAGNOSTIC INVESTIGATIONS IN CHRONIC INFLAMMATORY DEMYELINATING POLIRADICULONEUROPATHY: DATA FROM THE ITALIAN CIDP DATABASE 73
The role of mitochondria in neurodegenerative diseases 73
Progress in enzyme replacement therapy in glycogen storage disease type II 73
Clinical spectrum and evolution of monoclonal gammopathy-associated neuropathy: An observational study 73
Plasma amino acids patterns and age of onset of amyotrophic lateral sclerosis 73
Becker muscular dystrophy due to an intronic splicing mutation inducing a dual dystrophin transcript 73
Course and management of allogeneic stem cell transplantation in patients with mitochondrial neurogastrointestinal encephalomyopathy 73
Imaging of the muscle 72
A novel KCNA1 mutation in a patient with paroxysmal ataxia, myokymia, painful contractures and metabolic dysfunctions 72
A mitochondrial DNA duplication as a marker of skeletal muscle specific mutations in the mitochondrial genome 72
Late-onset glycogen storage disease type 2 72
A novel mitochondrial tRNAPhe mutation causes MERRF syndrome 72
Pitfalls in diagnosing mitochondrial neurogastrointestinal encephalomyopathy 72
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE-MTDPS1) 72
The role of brain MRI in mitochondrial neurogastrointestinal encephalomyopathy 71
Reversible upper limb muscle weakness with selective loss of thick filaments 71
"Mitochondrial neuropathies": A survey from the large cohort of the Italian Network 71
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 71
Current options in the treatment of mitochondrial diseases 69
The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study 68
A novel mutation in motor domain of KIF5A associated with an HSP/axonal neuropathy phenotype 68
On the Comparison of Markov Chains-based Models in Process Mining for Healthcare: A Case Study 67
Clinical and Molecular Spectrum of Myotonia and Periodic Paralyses Associated With Mutations in SCN4A in a Large Cohort of Italian Patients 67
Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database 67
Digital health and Clinical Patient Management System (CPMS) platform utility for data sharing of neuromuscular patients: the Italian EURO-NMD experience 66
Totale 10.289
Categoria #
all - tutte 128.105
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 128.105


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.930 0 0 0 0 0 262 134 384 271 485 104 290
2021/20221.225 27 293 25 39 11 81 137 91 85 57 115 264
2022/2023860 223 22 22 21 50 266 3 53 103 13 36 48
2023/20241.565 61 29 146 57 56 267 47 45 487 27 38 305
2024/20253.934 28 11 48 503 459 322 268 87 550 360 775 523
2025/20265.132 731 1.283 719 1.287 716 396 0 0 0 0 0 0
Totale 18.443